In vitrouptake and antimycobacterial activity of liposomal usnic acid formulation

References

• Ahsan, F., Rivas, I. R., Khan, M. A., Torres Suárez, A. I. (2002). Targeting to macrophages: role of physicochemical properties of particulate carriers—liposomes and microspheres—on the phagocytosis by macrophages. J Control Rel 79:29–40.
   PubMed Web of Science ®Google Scholar
• Allen, T. M., Austin, G. A., Chonn, A., Lin, L., Lee, K. C.(1991). Uptake of liposomes by cultured mouse bone marrow macrophages: influence of liposome composition and size. Bioch Biophys Acta 1061:56–64.
   PubMed Web of Science ®Google Scholar
• Alley, M. C., Scudiero, D. A., Monsk, A., Hursey, M. L., Czerwinski, M. J., Fine, D. L., Abott, B. J., Mayo, J. G., Shoemaker, R. H., Boyd, M. R.(1988). Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Cancer Res 48:589–601.
   PubMed Web of Science ®Google Scholar
• Alving, C. R.(1988). Macrophages as targets for delivery of liposome-encapsulated antimicrobial agents. Adv Drug Del Rev 2:107–128.
   Google Scholar
• Andrade, C. A. S., Correia, M. T. S., Coelho, L. C. B. B., Nascimento, S. C., Santos-Magalhães, N. S. (2004). Antitumor activity of Cratylia mollis lectin encapsulated into liposomes. Int J Pharm 278:435–445.
   Google Scholar
• Andrade, C. A. S., Melo, C. P., Santos-Magalhães, N. S.(2006). Thermodynamic characterization of the prevailing molecular interaction in mixed floating monolayers of phospholipids and usnic acid. J Colloid Int Sci 298:145–153.
   Google Scholar
• Campanella, L., Delfini, M., Ercole, P., Iacoangeli, A., Risuleo, G. (2002). Molecular characterization and action of usnic acid: a drug that inhibits proliferation of mouse polyomavirus in vitro and whose main target is RNA transcription. Biochimie 84:329–334.
   PubMedGoogle Scholar
• Cocchietto, M., Skert, N., Nimis, P. L., Sava, G.(2002). A review on usnic acid, an interesting natural compound. Naturwissenschaften 89:137–146.
   PubMed Web of Science ®Google Scholar
• Collins, L. A., Franzblau, S. G.(1997). Microplate Alamar blue assay versus BACTEC 460 System for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium. Antimicrob Agents Chemother 41:1004–1009.
   PubMed Web of Science ®Google Scholar
• Crosasso, P., Ceruti, M., Brusa, P., Arpico, S., Dosio, F., Cattel, L.(2000). Preparation, characterization, and properties of sterically stabilized paclitaxel-containing liposomes. J Control Rel 63:19–30.
   PubMed Web of Science ®Google Scholar
• Daffé, M., Etienne, G.(1999). The capsule of Mycobacterium tuberculosis and its implications for pathogenicity. TubLung Dis 79:153–169.
   Google Scholar
• Deol, P., Khuller, G. K. (1997). Lung specific stealth liposomes: stability, biodistribution, and toxicity of liposomal antitubercular drugs in mice. Biochim Biophys Acta 1334:161–172.
   PubMed Web of Science ®Google Scholar
• Duncan, K., Barry, C. E., III. (2004). Prospects for new antitubercular drugs. Curr Opin Microbiol 7:460–465.
   PubMed Web of Science ®Google Scholar
• Düzgünes, N., Flasher, D., Reddy, M. V., Luna-Herrera, J., Gangadharam, P. R. J. (1996). Treatment of intracellular Mycobacterium avium complex infection by free and liposome-encapsulated Sparfloxacin. Antimicrob Agents Chemother 40:2618–2621.
   PubMed Web of Science ®Google Scholar
• Düzgüneş, N., Nir, S.(1999). Mechanisms and kinetics of liposome-cell interactions. Adv Drug Del Rev 40:3–18.
   PubMed Web of Science ®Google Scholar
• Francolini, I., Narris, P., Piazzi, A., Donelli, G., Stoodley, P.(2004). Usnic acid, a natural antimicrobial agent able to inhibit bacterial biofilm formation on polymer surfaces. Antimicrob Agents Chemother 48:4360–4365.
   PubMed Web of Science ®Google Scholar
• Gürsoy, A., Kut, E., özkirimli, S.(2004). Coencapsulation of isoniazid and rifampicin in liposomes and characterization of liposomes by derivate spectroscopy. Int J Pharm 271:115–123.
   PubMed Web of Science ®Google Scholar
• Herrmann, J. L., Lagrange, P. H. (2005). Dendritic cells and Mycobacterium tuberculosis: which is the Trojan horse? Pathol Biol 53:35–40.
   Google Scholar
• Hsu, M. J., Juliano, R. L.(1982). Interactions of liposomes with the reticuloendothelial system. II: Nonspecific and receptor- mediated uptake of liposomes by mouse peritoneal macrophages. Biochim Biophys Acta 720:411–419.
   PubMed Web of Science ®Google Scholar
• Huth, U. S., Schubert, R., Peschka-Süss, R.(2006). Investigating the uptake and intracellular fate of pH-sensitive liposomes by flow cytometry and spectral bio-imaging. J Control Rel 110:490–504.
   PubMed Web of Science ®Google Scholar
• Ingólfsdóttir, K.(2002). Molecules of interest: usnic acid. Phytochemistry 61:729–736.
   PubMed Web of Science ®Google Scholar
• Ingólfsdóttir, K., Chung, G. A. C., Skúlason, V. G., Gissurarson, S. R., Vilhelmsdóttir, M. (1998). Antimycobacterial activity of lichen metabolites in vitro. Eur J Pharm Sci 6:141–144.
   PubMed Web of Science ®Google Scholar
• Kristmundsdóttir, T., Aradóttir, H. A. E., Ingólfsdóttir, K., ögmundsóttir, H. M.(2002). Solubilization of the lichen metabolite (+)-usnic acid for testing in tissue culture. J Pharm Pharmacol 54:1447–1452.
   PubMed Web of Science ®Google Scholar
• Kristmundsdóttir, T., Jónsdóttir, E., ögmundsóttir, H. M., Ingólfsdóttir, K. (2005). Solubilization of poorly soluble lichen metabolites for biological testing on cell lines. Eur J Pharm Sci 24:539–543.
   PubMed Web of Science ®Google Scholar
• Lauterwein, M., Oethinger, M., Belsner, K., Peters, T., Marre, R.(1995). In vitro activities of the lichen secondary metabolites vulpinic acid, (+)-usnic acid, and (-)-usnic acid against aerobic and anaerobic microorganisms. Antimicrob Agents Chemother 39:2541–2543.
   PubMed Web of Science ®Google Scholar
• Mayer, M., Murray, K. E., Neill, M. A. O., Santos-Magalhães, N. S., Carneiro-Leão, A. M. A., Thompson, A. M., Appleyard, M. V. C. L. (2005). Usnic acid, a nongenotoxic compound with anti-cancer properties. Anticancer Drugs 16:805–809.
   PubMed Web of Science ®Google Scholar
• Oh, Y. K., Nix, D. E., Straubinger, R. M.(1995). Formulation and efficacy of liposome-encapsulated antibiotics for therapy of intracellular Mycobacterium avium infection. Antimicrob Agents Chemother 39:2104–2111.
   PubMed Web of Science ®Google Scholar
• Oh, Y. K., Straubinger, R. M. (1997). Impact of Mycobacterium avium infection on macrophage-liposome interaction. J Liposome Res 7:101–114.
   Google Scholar
• Perry, N. B., Benn, M. H., Brennan, N. J., Burgess, E. J., Elliss, G., Galloway, D. J., Loriner, S. D., Tangney, R. S.(1999). Antimicrobial, antiviral, and cytotoxic activity of New Zealand lichens. Lichenologist 31:627–636.
   Web of Science ®Google Scholar
• Pinto-Alphandary, H., Andremont, A., Couvreur, P.(2000). Targeted delivery of antibiotics using liposomes and nanoparticles: research and applications. Int J Antimicrob Agents 13:155–168.
   PubMed Web of Science ®Google Scholar
• Raviglione, M. C.(2003). The TB epidemic from 1992 to 2002. Tuberculosis 83:4–14.
   PubMed Web of Science ®Google Scholar
• Ribeiro-Costa, R. M., Alves, A. J., Santos, N. P., Nascimento, S. C., Gonçalves, E. C. P., Silva, N. H., Honda, N. K., Santos-Magalhães, N. S. (2004). In vitro and in vivo properties of usnic acid encapsulated into PLGA-microspheres. J Microencapsul 21:371–384.
   PubMed Web of Science ®Google Scholar
• Saarinen-Savolainen, P., Järvinen, T., Taipale, H., Urtti, A. (1997). Method for evaluating drug release from liposomes in sink conditions. Int J Pharm 159:27–33.
   Web of Science ®Google Scholar
• Salem, I. I., Düzgünes, N.(2003). Efficacies of cyclodextrin- complexed and liposome encapsulated clarithromycin against Mycobacterium avium complex infection in human macrophages. Int J Pharm 250: 403–414.
   PubMed Web of Science ®Google Scholar
• Santos, N. P., Nascimento, S. C., Silva, J. F., Pereira, E. C. G., Silva, N. H., Honda, N. K., Santos-Magalhães, N. S.(2005). Usnic acid-loaded nanocapsules: an evaluation of cytotoxicity. J Drug Deliv Sci Tech 15:355–361.
   Google Scholar
• Santos, N. P., Nascimento, S. C., Wanderley, M. S. O., Telles, N., Castro, C. M. M. B., Pereira, E. C., Silva, N. H., Honda, N. K., Santos-Magalhães, N. S.(2006). Nanoencapsulation of usnic acid: an attempt to improve antitumour activity and reduce hepatotoxicity. Eur J Pharm Biopharm 64:154–160.
   PubMed Web of Science ®Google Scholar
• Sharma, R. K., Jannke, P. J.(1966). Acidity of usnic acid. Ind J Chem 4:16–18.
   Google Scholar
• Sharma, A., Sharma, U. S.(1997). Liposomes in drug delivery: progress and limitations. Int J Pharm 154:123–140.
   Web of Science ®Google Scholar
• Schwendener, R. A., Lagocki, P. A., Rahman, Y. E.(1984). The effects of charge and size on the interaction of unilamellar liposomes with macrophages. Biochim Biophys Acta 772:93–101.
   PubMed Web of Science ®Google Scholar
• Siqueira-Moura, M. P., Lira, M. C. B., Santos-Magalhães, N. S.(2008). Validação de Método Analítico Espectrofotométrico UV para Determinação de ácido úsnico em Lipossomas. Braz J Pharm Sci (in press).
   Google Scholar
• Torchilin, V. P. (2005). Recent advances with liposomes as pharmaceutical carriers. Nature Rev Drug Discov 4:145–160.
   PubMed Web of Science ®Google Scholar
• Torchilin, V. P. (2006). Multifunctional nanocarriers. Adv Drug Deliv Rev 58:1532–1555.
   PubMed Web of Science ®Google Scholar
• Tran, T., Saheba, E., Arcerio, A. V., Chavez, V., Li, Q-Y., Martinez, L. E., Primm, T. P.(2004). Quinones as antimycobacterial agents. Bioorg Med Chem 12:4809–4813.
   PubMed Web of Science ®Google Scholar
• Wong, J. P., Yang, H., Blasetti, K. L., Schnell, G., Conley, J., Schofiels, L. N.(2003). Liposome delivery of ciprofloxacin against intracellular Francisella tularensis infection. J Contr Rel 92:265–273.
   PubMed Web of Science ®Google Scholar